USP–NF Publication Schedule
| Publication | Release/Posting Date | Official Date (unless otherwise indicated) |
|---|---|---|
| Second Supplement to USP 42–NF 37 | June 1, 2019 | Dec. 1, 2019 |
| USP 43–NF 38 | Nov. 1, 2019 | Nov. 1, 2020* |
| First Supplement to USP 43–NF 38 | Feb 3, 2020 | Nov. 1, 2020* |
| Second Supplement to USP 43–NF 38 | June 1, 2020 | Dec. 1, 2020 |
| USP–NF 2021, Issue 1 | Nov. 1, 2020 | May 1, 2021 |
| USP–NF 2021, Issue 2 | Feb. 1, 2021 | Aug. 1, 2021 |
| USP–NF 2021, Issue 3 | June 1, 2021 | Dec. 1, 2021 |
| USP–NF 2022, Issue 1 | Nov. 1, 2021 | May 1, 2022 |
*Please see this Notice regarding delayed implementation and comment period extension for USP–NF publications
(The USP–NF is also published as a Spanish Edition. View Spanish Edition publication schedule. Official dates are the same.)
Pharmacopeial Forum Posting, Comment Deadline, IRA Posting and Official Dates, and Target Publication Schedule
|
PF |
PF Posting Date |
Comment Due Date |
Target Official Publication for In-Process Revision Proposals and Official Dates |
Target IRA Posting Date; Online Publication |
IRA Official Date |
Print Publication into which IRAs Are Incorporated |
|---|---|---|---|---|---|---|
| 45(6) | November 1, 2019 | January 31, 2020 | USP–NF 2021, Issue 1 | March 27, 2020 | May 1, 2020 | N/A |
| 46(1) | January 2, 2020 | March 31, 2020 | USP–NF 2021, Issue 1 | May 29, 2020 | July 1, 2020 | N/A |
| 46(2) | March 1, 2020 | July 31, 2020* | USP–NF 2021, Issue 2 | September 25, 2020 | November 1, 2020 | N/A |
| 46(3) | May 1, 2020 |
July 31, 2020 (IRAs) August 1, 2020 (in process revisions)** |
USP–NF 2021, Issue 3 | September 25, 2020 | November 1, 2020 | N/A |
| 46(4) | July 1, 2020 | September 30, 2020 | USP–NF 2021, Issue 3 | November 20, 2020 | January 1, 2021 | N/A |
| 46(5) | September 1, 2020 | November 30, 2020 | USP–NF 2021, Issue 3 | January 29, 2021 | March 1, 2021 | N/A |
*Please see this Notice regarding delayed implementation and comment period extension for USP–NF publications.
** Please see this Notice regarding extended comment period for Pharmacopeial Forum 46(3).